Captions were auto-generated.
Black women had the lowest moderate-to-vigorous-intensity physical activity (MVPA) scores when compared with their male counterparts and White men and women in a recent study evaluating physical activity trajectories before and after a cardiovascular disease (CVD) event. The American Journal of Managed Care® spoke with Melvin Echols, MD, the chief DEI officer of the American College of Cardiology, associate professor of medicine in cardiovascular disease at Morehouse School of Medicine, and associate director of clinical research at the Cardiovascular Research Institute, to discuss the topic at hand.
Echols attributed the disproportionate MVPA scores amongst Black women to social drivers of health. Referencing his upbringing, being raised by a single mother after his father passed, Echols witnessed firsthand the responsibilities associated with being a Black woman, often underappreciated within their communities. Echols believes that although Black women serve as pillars in their families and communities, “it comes at an adverse risk to herself.”
Not only are Black women at an adverse risk for CVD events, like coronary heart disease, stroke, and heart failure, but so are Black men. Their MVPA scores peaked in their youth and early twenties—much higher when compared with White men and women—and maintained a persistent decline throughout the rest of their lives.1 While Black women and men saw MVPA continue to decline throughout their lives, White men and women saw a rebound in their mid-40s to late 50s in MVPA scores.
Another study, when solely measuring physical activity throughout the lives of Black individuals, saw MVPA was highest amongst men, younger age groups, groups with the highest education and income, and those who were employed or married.2
Echols also suggested that what constitutes MVPA to most people may not be common knowledge, and while the American Heart Association provides recommendations on the amount of time an individual should be active, it is not hyper-specific to any type of physical activity. However, it does suggest connecting with others through community exercise and incorporating any variation of weekly strength training.
References
1. Gerber Y, Pettee Gabriel K, Jacobs DR, et al. Trajectories of physical activity before and after cardiovascular disease events in CARDIA participants. JAMA Cardiol. Published online July 23, 2025. doi:10.1001/jamacardio
2. Williams WM, Yore MM, Whitt-Glover MC. Estimating physical activity trends among Blacks in the United States through examination of four national surveys. AIMS Public Health. 2018 May 29;5(2):144-157. doi:10.3934/publichealth.2018.2.144
Social Drivers of Health Can Impact Regular Exercise, Increase CVD Risk: Melvin Echols, MD
Melvin Echols, MD
Social drivers of health are determined primarily by an individual’s economic stability, access to quality education, and health care. These factors also play a key role in the proportion of moderate-to-vigorous-intensity physical activity (MVPA) in an individual’s lifetime, which can also impact their cardiovascular disease (CVD) risk.
Captions were auto-generated.
Black women had the lowest moderate-to-vigorous-intensity physical activity (MVPA) scores when compared with their male counterparts and White men and women in a recent study evaluating physical activity trajectories before and after a cardiovascular disease (CVD) event. The American Journal of Managed Care® spoke with Melvin Echols, MD, the chief DEI officer of the American College of Cardiology, associate professor of medicine in cardiovascular disease at Morehouse School of Medicine, and associate director of clinical research at the Cardiovascular Research Institute, to discuss the topic at hand.
Echols attributed the disproportionate MVPA scores amongst Black women to social drivers of health. Referencing his upbringing, being raised by a single mother after his father passed, Echols witnessed firsthand the responsibilities associated with being a Black woman, often underappreciated within their communities. Echols believes that although Black women serve as pillars in their families and communities, “it comes at an adverse risk to herself.”
Not only are Black women at an adverse risk for CVD events, like coronary heart disease, stroke, and heart failure, but so are Black men. Their MVPA scores peaked in their youth and early twenties—much higher when compared with White men and women—and maintained a persistent decline throughout the rest of their lives.1 While Black women and men saw MVPA continue to decline throughout their lives, White men and women saw a rebound in their mid-40s to late 50s in MVPA scores.
Another study, when solely measuring physical activity throughout the lives of Black individuals, saw MVPA was highest amongst men, younger age groups, groups with the highest education and income, and those who were employed or married.2
Echols also suggested that what constitutes MVPA to most people may not be common knowledge, and while the American Heart Association provides recommendations on the amount of time an individual should be active, it is not hyper-specific to any type of physical activity. However, it does suggest connecting with others through community exercise and incorporating any variation of weekly strength training.
References
1. Gerber Y, Pettee Gabriel K, Jacobs DR, et al. Trajectories of physical activity before and after cardiovascular disease events in CARDIA participants. JAMA Cardiol. Published online July 23, 2025. doi:10.1001/jamacardio
2. Williams WM, Yore MM, Whitt-Glover MC. Estimating physical activity trends among Blacks in the United States through examination of four national surveys. AIMS Public Health. 2018 May 29;5(2):144-157. doi:10.3934/publichealth.2018.2.144
5 Things to Know About the Oral GLP-1 Era
February 6th 2026Oral semaglutide (Wegovy; Novo Nordisk) expands GLP-1 weight-loss options, but pharmacy budgets and health care cost pressures persist.
Read More
The Orphan Drug Act in the Modern Drug Pricing Era
February 3rd 2026Policy strategist Kristi Martin discusses how the Orphan Drug Act reshapes rare disease treatment and drug-pricing challenges.
Listen
Closing Gaps in Stroke Care Starts With Defining the US Health Care Safety Net
February 5th 2026Clearer definitions, tailored programs and policies, and telestroke care could help close rural stroke care disparities.
Read More
Reflecting on 15 Years of Health IT Evolution and What’s Next: Nate C. Apathy, PhD
January 27th 2026Nate C. Apathy, PhD, guest editor of AJMC's 15th Health IT special issue, calls for tools to be closely aligned with user needs.
Listen
New Molecular Drivers of HER2 Breast Cancer Resistance: A Q&A With Ateequllah Hayat, PhD
February 4th 2026Ateequllah Hayat, PhD, discusses epigenetic rewiring, biomarkers, and emerging strategies to overcome lapatinib resistance in HER2+ breast cancer.
Read More
PBM Reforms Signed Into Law, Reshaping Medicare Part D Drug Pricing Transparency
February 3rd 2026A spending bill advancing PBM reforms aims to delink Medicare Part D compensation from drug rebates and improve pricing transparency.
Read More
5 Things to Know About the Oral GLP-1 Era
February 6th 2026Oral semaglutide (Wegovy; Novo Nordisk) expands GLP-1 weight-loss options, but pharmacy budgets and health care cost pressures persist.
Read More
The Orphan Drug Act in the Modern Drug Pricing Era
February 3rd 2026Policy strategist Kristi Martin discusses how the Orphan Drug Act reshapes rare disease treatment and drug-pricing challenges.
Listen
Closing Gaps in Stroke Care Starts With Defining the US Health Care Safety Net
February 5th 2026Clearer definitions, tailored programs and policies, and telestroke care could help close rural stroke care disparities.
Read More
Reflecting on 15 Years of Health IT Evolution and What’s Next: Nate C. Apathy, PhD
January 27th 2026Nate C. Apathy, PhD, guest editor of AJMC's 15th Health IT special issue, calls for tools to be closely aligned with user needs.
Listen
New Molecular Drivers of HER2 Breast Cancer Resistance: A Q&A With Ateequllah Hayat, PhD
February 4th 2026Ateequllah Hayat, PhD, discusses epigenetic rewiring, biomarkers, and emerging strategies to overcome lapatinib resistance in HER2+ breast cancer.
Read More
PBM Reforms Signed Into Law, Reshaping Medicare Part D Drug Pricing Transparency
February 3rd 2026A spending bill advancing PBM reforms aims to delink Medicare Part D compensation from drug rebates and improve pricing transparency.
Read More